Abstract
The clavams valclavam and hydroxyethylclavam were both bacteriostatic and fungistatic. The molecular basis for growth inhibition of Escherichia coli was a non-competitive inhibition of homoserine-O-succinyltransferase (EC 2.3.1.46), thus blocking methionine biosynthesis. Eucaryotes such as Saccharomyces cerevisiae were inhibited by a different mode of action. Instead of interfering with methionine biosynthesis, the clavams inhibited the formation of RNA in living cells, although the RNA-polymerases of isolated yeast nuclei were not inhibited. The action of valclavam on E. coli was dependent on functional peptide transport systems.
Similar content being viewed by others
Abbreviations
- CoA:
-
coenzyme A
- mic:
-
mimimal inhibitory concentration
- SAM:
-
S-adenosylmethionine
- TCA:
-
trichloroacetic acid Offprint requests to: H. Zähner
References
Brown D, Evans JR, Fletton RA (1979) Structures of three novel β-lactams isolated from Streptomyces clavuligerus. J Chem Soc Chem Commun 1979:282–283
Dähn U, Hagenmaier H, Höhne H, König H, Wolf G, Zähner H (1976) Nikkomycin, ein neuer Hemmstoff der Chitinsynthase bei Pilzen. Arch Microbiol 107:142–160
Davis BP, Mingioli ES (1950) Mutants of Escherichia coli requiring methionine or vitamine B12. J Bacteriol 60:17–28
Delaney SF, Dickson A, Carr NG (1973) The control of homoserine-O-transsuccinylase in a methionine requiring mutant of the blue-greenaalga Anacystis nidulans. J Gen Microbiol 79:89–94
Diddens H, Dorgerloh M, Zähner H (1979) Metabolic products of microorganisms 176: On the transport of small peptide antibiotics in bacteria. J Antibiotics 32:87–90
Duffus JH (1974) the isolation of yeast nucleic and methods to study their properties. Meth Cell Biol 12:77–97
Eikhom TS, Jonsen J, Laland S, Refsvik T (1963) On the biosynthesis of gramicidin S. Biochem Biophys Acta 76:465–468
Guggenheim S (1971) β-cystathionase (Salmonella). Meth Enzymol 17b:439–422
Hamamoto T, Uozumi T, Beppu T (1985) Leptomycins A and B, new antifungal antibiotics III. Mode of action of Leptomycin B on Schizosaccharomyces pombe. J Antibiotics 38:1573–1580
Hopwood D (1967) Genetic analysis and genome structure in Streptomyces coelicolor. Bacteriol Rev 31:373–403
Hütter R, Keller-Schierlein W, Nüesch J, Zähner H (1965) Stoffwechselprodukte von Mikroorganismen. 48. Mitteilung. Scopamycine. Arch Microbiol 51:1–8
Jerome JF, Jaehning JA (1986) mRNA transcription in nuclei isolated from Saccharomyces cerevisiae. Mol Cell Biol 6:1633–1639
Kaplan M, Guggenheim S (1971) Cystathionine-gamma-synthase (Salmonella). Meth Enzymol 17b:425–433
King HD, Langhaerig J, Sanglier JJ (1986) Clavamycins: New clavam antibiotics from two variants of Streptomyces hygroscopicus. I. Taxonomy of the producing organisms, fermentation and biological activities. J Antibiotics 39:510–515
Lee LW, Ravel JM, Shive W (1966) Multimetabolite control of a biosynthetic pathway by sequential metabolites. J Biol Chem 241:5479–5480
May R (1971) Isolationsbedingungen für Zellkerne aus Hefeprotoplasten. Z Allg Mikrobiol 11:131–142
McCarthy PJ, Troke PF, Gull K (1985) Mechanism of action of nikkomycin and the peptide transport system of Candida albicans. J Gen Microbiol 131:775–778
Mitchson JM (1970) Physiological and cytological methods for Schizosaccharomyces pombe. Meth Cell Physiol 4:131–165
Moneton P, Sarthou P, Le Goffic F (1986) Role of nitrogen source in peptide transport in Saccharomyces cerevisiae. FEMS Letters 36:95–98
Müller JL, Toome V, Pruess DL, Blount JF, Weigele M (1983) Ro 22-5417. A new clavam antibiotic from Streptomyces clavuligerus. III. Absolute stereochemistry. J Antibiotics 36:217–225
Onishi H, McCance ME, Gibbons NE (1965) A synthetic medium for extremely halophilic bacteria. Can J Microbiol 11:365–373
Peter H, Rabenhorst J, Röhl F, Zähner H (1985) Valclavam An antifungal β-lactam antibiotic. In: Ishigami J (ed) Recent advances in chemotherapy. Antimicrobial section. University of Tokyo Press, pp 237–238
Peter H, Zähner H (1985) Clavam compounds. Patent Ger Offen 3427651
Payne JW, Gilvarg C (1978) Transport of peptides in bacteria. In: Rosen BP (ed) Bacterial transport. Plenum, New York, pp 325–383
Rabenhorst J (1986) Valclavam, ein antifungisches β-Lactam. Studien zur Fermentation, Isolierung, Biogenese und der biologischen Wirkung. Dissertation, Universität Tübingen
Reading C, Cole M (1977) Clavulanic acid: A β-lactamase inhibiting β-lactam from Streptomyces clavuligerus. Antim Agents Chemoth 11:852–857
Wanning M (1980) Hydroxyethylclavam und andere Antibiotica aus Streptomyces antibioticus Tü 1718. Dissertation, Universität Tübingen
Wanning M, Zähner H, Krone B, Zeeck A (1981) Ein neues antifungisches β-lactam-Antibioticum der Clavam-Reihe. Tetrah Letters 22:2539–2540
Yadan JC, Gonneau M, Sarthou P, Le Goffic F (1984) Sensitivity to nikkomycin Z in Candida albicans: Role of peptide permeases. J Bacteriol 160:884–888
Zähner H, Maas WK (1972) Biology of antibiotics. Springer, Berlin Heidelberg New York
Author information
Authors and Affiliations
Additional information
Metabolic products of microorganisms 241 (Metabolic products of microorganisms, 240. Rohr J, Zeeck A (1987) Urdamycins, new angucycline antibiotic form Streptomyces fradiae. II. Structural studies of urdamycin B to F. J Antibiotics, in press
Rights and permissions
About this article
Cite this article
Röhl, F., Rabenhorst, J. & Zähner, H. Biological properties and mode of action of clavams. Arch. Microbiol. 147, 315–320 (1987). https://doi.org/10.1007/BF00406126
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00406126